Neoprobe 2nd Quarter 2011 Earnings and Business Update Conference Call Invitation
July 25 2011 - 6:49PM
Business Wire
Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer
of innovative oncology surgical and diagnostic products, today
announced it would report its financial results for the second
quarter of 2011 on Wednesday, July 27, 2011 after market close. The
announcement will be followed by a conference call with the
investment community the following day, Thursday, July 28 at 8:30
am ET.
Neoprobe’s President and CEO, Dr. Mark Pykett, Senior Vice
President, Pharmaceutical Research and Clinical Development, Dr.
Fred Cope, and Senior Vice President and CFO, Brent Larson, will
provide a development and business update and will discuss the
Company’s financial results for the second quarter of 2011 during
the conference call. The conference call can be accessed as
follows:
Conference Call Information TO PARTICIPATE
LIVE: TO LISTEN TO A REPLAY:
Date:
Time:
Toll-free (U.S.) Dial in # :
International Dial in # :
July 28, 2011
8:30 AM ET
(877) 407-8031
(201) 689-8031
Available until:
Toll-free (U.S.) Dial in # :
International Dial in # :
Replay passcode:
Account #:
Conference ID #:
Aug 11, 2011
(877) 660-6853
(201) 612-7415
286
376433
About Neoprobe
Neoprobe is a biomedical company focused on enhancing oncology
patient care and improving patient benefit through
radiopharmaceutical product development. Neoprobe is actively
developing two radiopharmaceutical agent platforms – Lymphoseek®
and RIGScanTM CR – to help surgeons better identify and treat
certain types of cancer. Neoprobe’s subsidiary, Cira Biosciences,
Inc., is also advancing a patient-specific cellular therapy
technology platform called ACT. Neoprobe’s strategy is to deliver
superior growth and shareholder return by bringing to market novel
radiopharmaceutical agents and advancing the Company’s pipeline
program through continued investment and selective acquisitions.
For more information, please visit www.neoprobe.com.
Neoprobe Corp. Common Stock (AMEX:NEOP)
Historical Stock Chart
From Apr 2024 to May 2024
Neoprobe Corp. Common Stock (AMEX:NEOP)
Historical Stock Chart
From May 2023 to May 2024